Novartis: all 3,900 studies
Page 38 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- A Long Term Study of Clozapine in Patients With Treatment-resistant SchizophreniaCompletedNCT00154258Phase 2
- A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients.CompletedNCT00154245Phase 4
- Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)CompletedNCT00154232Phase 4
- Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip OsteoarthritisCompletedNCT00154219Phase 3
- Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant PatientsCompletedNCT00154206Phase 4
- Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 LevelsCompletedNCT00154193Phase 4
- Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsionTerminatedNCT00150085Phase 4
- Efficacy and Safety of Imatinib in ChordomaCompletedNCT00150072Phase 2
- Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic DermatitisCompletedNCT00150059Phase 4
- Efficacy and Safety of Everolimus in de Novo Heart Transplant RecipientsCompletedNCT00150046Phase 3
- Safety and Tolerability of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients With GI IntoleranceCompletedNCT00150020Phase 4
- Measurement of Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (PROGIS)CompletedNCT00150007Phase 4
- A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ TransplantationNo longer availableNCT00149981
- Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Renal Transplant Recipients (MyLife)CompletedNCT00149968Phase 4
- Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) TherapyCompletedNCT00149942Phase 4
- Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301CompletedNCT00149929Phase 3
- Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107CompletedNCT00149916Phase 3
- Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant PatientsCompletedNCT00149903Phase 3
- Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic ConstipationCompletedNCT00149877Phase 4
- Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302CompletedNCT00149864Phase 3
- A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)CompletedNCT00149851Phase 2
- 52 Week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability & Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid & Celecoxib 200 mg od in Pts With Primary OA of Hip, Knee, Hand or SpineCompletedNCT00145301Phase 3
- To Assess the Efficacy of Over-the-counter Analgesics in the Prevention/Treatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal WomenCompletedNCT00145275Phase 3
- Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United StatesCompletedNCT00143026Phase 4
- Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBSCompletedNCT00142987Phase 4
- Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic GastropathyTerminatedNCT00142974Phase 2
- Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.CompletedNCT00141089Phase 3
- Safety and Efficacy Study of Dexmethylphenidate in Children With ADHDCompletedNCT00141063Phase 3
- Safety and Efficacy Study of Dexmethylphenidate in Children With ADHDCompletedNCT00141050Phase 3
- Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I DisorderCompletedNCT00139594Phase 4
- Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric SubjectsCompletedNCT00139581Phase 4
- An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic ConstipationCompletedNCT00139568Phase 3
- Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk HypertensionCompletedNCT00139555Phase 4
- Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)CompletedNCT00138632Phase 1/2
- Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 DiabetesCompletedNCT00138619Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT00138606Phase 3
- Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11%CompletedNCT00138593Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 DiabetesCompletedNCT00138580Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 DiabetesCompletedNCT00138567Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 DiabetesCompletedNCT00138554Phase 3
- Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT00138541Phase 3
- Other Effects of Fluvastatin Are Investigated in Patients With Metabolic SyndromeCompletedNCT00138528Phase 4
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00138515Phase 3
- Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe HypertensionCompletedNCT00136851Phase 4
- Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary HypercholesterolemiaCompletedNCT00136799Phase 3
- Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes MellitusCompletedNCT00136773Phase 4
- Photodynamic Therapy in Occult-Only Lesions (POOL)CompletedNCT00135837Phase 4
- Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy VolunteersCompletedNCT00135824Phase 4
- Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)CompletedNCT00135005Phase 1
- A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy VolunteersCompletedNCT00134992Phase 4
- Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary DiseaseCompletedNCT00134979Phase 4
- A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/LevodopaCompletedNCT00134966Phase 3
- Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive ImpairmentTerminatedNCT00134953Phase 3
- Post-marketing Study to Collect Safety Data in Heart Transplant Patients Receiving EverolimusCompletedNCT00134940
- Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic ConjunctivitisCompletedNCT00133627Phase 4
- Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis BCompletedNCT00132652Phase 3
- Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis BCompletedNCT00131742Phase 3
- Octreotide Acetate in Microspheres in Patients With Diabetic RetinopathyCompletedNCT00131144Phase 3
- Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis ImperfectaCompletedNCT00131118Phase 2
- Octreotide Acetate in Microspheres in Patients With Diabetic RetinopathyCompletedNCT00130845Phase 3
- Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic DermatitisCompletedNCT00130364Phase 4
- A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With AsthmaCompletedNCT00130351Phase 3
- Rivastigmine Capsules in Patients With Probable Vascular DementiaCompletedNCT00130338Phase 3
- Study to Assess the Safety and Tolerability of Incremental Doses of QAB149 in Adults With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00129831Phase 2
- A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus SheddingCompletedNCT00129818Phase 4
- Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis BCompletedNCT00128544Phase 2
- Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis SiccaCompletedNCT00128245Phase 2
- Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic PatientsCompletedNCT00128232Phase 3
- Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive BladderCompletedNCT00127270Phase 4
- Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis SubjectsTerminatedNCT00125346Phase 3
- Fluvastatin in Adults With Dislipidemia With History of Muscle ProblemsCompletedNCT00125125Phase 4
- Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00124280Phase 2
- An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis BCompletedNCT00124241Phase 2
- Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic DermatitisCompletedNCT00121381Phase 4
- Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) PatientsCompletedNCT00121316Phase 4
- Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 DiabetesCompletedNCT00120536Phase 3
- Quality of Life Study in Adults With Facial EczemaCompletedNCT00120302Phase 4
- Study of Oral AEE788 in Adults With Advanced CancerCompletedNCT00118456Phase 1
- Terbinafine Compared to Griseofulvin in Children With Tinea CapitisCompletedNCT00117767Phase 3
- Terbinafine Compared to Griseofulvin in Children With Tinea CapitisCompletedNCT00117754Phase 3
- Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic DermatitisCompletedNCT00117377Phase 4
- Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)CompletedNCT00116376Phase 1/2
- Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis BCompletedNCT00115245Phase 3
- Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 DiabetesCompletedNCT00110240Phase 3
- Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety DisorderCompletedNCT00108836Phase 2
- Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine TherapyTerminatedNCT00108108Phase 1
- Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar DisorderCompletedNCT00107939Phase 3
- Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar DisorderCompletedNCT00107926Phase 3
- AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma MultiformeCompletedNCT00107237Phase 1/2
- Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal WomenCompletedNCT00107016Phase 2
- Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00106340Phase 3
- Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's DiseaseCompletedNCT00104442Phase 4
- Pharmacokinetics/Pharmacodynamics (PK/PD) of CangrelorCompletedNCT00102674Phase 1
- Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00102466Phase 3
- Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 DiabetesCompletedNCT00102388Phase 3
- Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 DiabetesCompletedNCT00101803Phase 3
- Freedom Study: Myfortic in Kidney Transplant PatientsCompletedNCT00101738Phase 3
- Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild HyperglycemiaCompletedNCT00101712Phase 3
- Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%CompletedNCT00101673Phase 3
- Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced OsteoporosisCompletedNCT00100620Phase 3